Related Experiment Video
Updated: Feb 3, 2026

Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET
Published on: October 9, 2021
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives
Shengnan Zhang1, Fangfei Qi1, Xin Fang1
1State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, Songhu Road 2005, Shanghai, 200438, China.
Abstract:
Tryptophan 2,3-dioxygenase (TDO) is becoming a promising therapeutic target due to its involvement in cancer and neurodegenerative diseases. Development of efficient TDO inhibitors is a prime strategy in disease treatment. However, the lack of a TDO inhibitor bioassay system slows the progress of TDO inhibitor research. Herein, an active recombinant human TDO (hTDO) was prepared under optimal expression conditions, an enzymatic assay was optimized, and two cellular assays of TDO activity were developed. Then, the potential TDO inhibitory activities of nine tryptanthrin derivatives (5a-5i) were evaluated, and the inhibitory constants (Ki), enzymatic and cellular half maximal inhibitory concentrations (IC50) were measured, and the type of inhibition was determined. The tryptanthrins had various levels of TDO inhibitory activities; tryptanthrins with a substituent at 8-position had stronger inhibitory activities than the other derivatives. Moreover, most of the compounds, except 5g and 5h, exhibited better inhibitory activities than the previously reported TDO inhibitor LM10. Furthermore, the molecular docking study of compounds 5c and 5d revealed that the O atom of the tryptanthrin ring is directed toward the heme iron (Fe) of hTDO via strong coordination interactions. These findings suggest that tryptanthrin and its derivatives have the potential to be developed as promising molecules for TDO-related target therapy.
Insights
Tryptophan 2,3-dioxygenase (TDO) inhibitors are crucial for treating cancer and neurodegenerative diseases. This study developed new bioassays and found that tryptanthrin derivatives show potent TDO inhibitory activity, offering potential therapeutic strategies.
Area of Science:
- Biochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Tryptophan 2,3-dioxygenase (TDO) is a key enzyme implicated in cancer and neurodegenerative diseases.
- Developing effective TDO inhibitors is critical for therapeutic intervention.
- A lack of robust bioassay systems has hindered TDO inhibitor research.
Purpose of the Study:
- To develop and optimize bioassay systems for TDO activity.
- To evaluate the TDO inhibitory potential of nine tryptanthrin derivatives.
- To characterize the inhibitory mechanism and potency of active compounds.
Main Methods:
- Preparation of active recombinant human TDO (hTDO).
- Optimization of enzymatic and development of cellular TDO activity assays.
- In vitro evaluation of tryptanthrin derivatives' inhibitory activity, including IC50 and Ki determination.
- Molecular docking studies to elucidate binding interactions.
Main Results:
- Established functional enzymatic and cellular assays for TDO activity.
- Identified nine tryptanthrin derivatives with varying TDO inhibitory effects.
- Tryptanthrins with 8-position substituents demonstrated enhanced inhibitory activity.
- Most compounds showed superior inhibition compared to the known inhibitor LM10.
- Molecular docking revealed coordination interactions between tryptanthrin derivatives and hTDO's heme iron.
Conclusions:
- Tryptanthrin derivatives represent a promising class of compounds for TDO inhibition.
- The developed bioassays facilitate further research in TDO inhibitor discovery.
- These findings support the potential development of tryptanthrins for TDO-targeted therapies in relevant diseases.
More Related Videos
Related Concept Videos
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Excitatory and Inhibitory Effects of Neurotransmitters
Measurement: Derived Units
Primary Active Transport
Higher Derivatives
Derivatives

![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)